The role of adenosine 5′-diphosphate receptor blockade in patients with cardiovascular disease
- 1 July 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (1) , 45-53
- https://doi.org/10.1016/s0002-9343(01)00761-6
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2000
- Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac diseaseProgress in Cardiovascular Diseases, 1997
- Mechanisms Initiating Platelet Thrombus FormationThrombosis and Haemostasis, 1997
- ADP-lnduced Platelet ActivationCritical Reviews in Biochemistry and Molecular Biology, 1997
- Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole bloodBlood Coagulation & Fibrinolysis, 1996
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Aspirin response and failure in cerebral infarction.Stroke, 1993
- Glycoprotein Ia/IIa-mediated activation-dependent platelet adhesion to collagenThrombosis Research, 1992
- Platelet Membrane Glycoproteins: Functions in Cellular InteractionsAnnual Review of Cell Biology, 1990
- Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIaBlood, 1987